US EditionPublished • loading... • Updated
Mergers and Acquisitions (M&A): Fibronostics Acquires Stone Clinical Laboratories
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mergers and Acquisitions (M&A): Fibronostics Acquires Stone Clinical Laboratories
New Orleans, Louisiana – Fibronostics has announced the acquisition of STONE Diagnostics (https://stonediagnostics.com/). According to the company announcement Fibronostics is a global health technology company that specializes in developing non-invasive diagnostic solutions for chronic diseases, with a particular focus on liver and metabolic disorders. The company’s main platform, LIVERFASt, allows clinicians to assess liver health with speed, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
